Thyroid Stimulating Hormone Is Increased in Hypertensive Patients with Obstructive Sleep Apnea

Purpose. To evaluate alteration in serum TSH in hypertensives with OSA and its relation with cardiometabolic risk factors. Methods. 517 hypertensives were cross-sectionally studied. OSA was determined by polysomnography and thyroid function by standard methods. Results. OSA was diagnosed in 373 hype...

Full description

Saved in:
Bibliographic Details
Main Authors: Nanfang Li, Mulalibieke Heizhati, Chao Sun, Suofeiya Abulikemu, Liang Shao, Xiaoguang Yao, Yingchun Wang, Jing Hong, Ling Zhou, Lei Wang, Yu Zhang, Weiwei Zhang
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2016/4802720
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832545651306528768
author Nanfang Li
Mulalibieke Heizhati
Chao Sun
Suofeiya Abulikemu
Liang Shao
Xiaoguang Yao
Yingchun Wang
Jing Hong
Ling Zhou
Lei Wang
Yu Zhang
Weiwei Zhang
author_facet Nanfang Li
Mulalibieke Heizhati
Chao Sun
Suofeiya Abulikemu
Liang Shao
Xiaoguang Yao
Yingchun Wang
Jing Hong
Ling Zhou
Lei Wang
Yu Zhang
Weiwei Zhang
author_sort Nanfang Li
collection DOAJ
description Purpose. To evaluate alteration in serum TSH in hypertensives with OSA and its relation with cardiometabolic risk factors. Methods. 517 hypertensives were cross-sectionally studied. OSA was determined by polysomnography and thyroid function by standard methods. Results. OSA was diagnosed in 373 hypertensives (72.15%). Prevalence of subclinical hypothyroidism was significantly higher in OSA hypertensives than in non-OSA ones (15.0% versus 6.9%, P=0.014). Serum LnTSH in hypertensives with severe OSA was significantly higher (0.99±0.81 versus 0.74±0.77 μIU/mL, P<0.05) than in those without OSA. AHI, LSaO2, ODI3, and ODI4 were independently associated with serum TSH for those aged 30–65 years. Dividing subjects into four groups as TSH < 1.0 μIU/mL, 1.0 ≤ THS ≤ 1.9 μIU/mL, 1.91 ≤ TSH < 4.5 μIU/mL, and TSH ≥ 4.5 μIU/mL, only 26.3% of OSA subjects exhibited TSH between 1.0 and 1.9 μIU/mL, significantly less than non-OSA subjects (26.3% versus 38.2%, P=0.01). DBP and serum LDL-c elevated with TSH increasing and were only significantly higher in TSH ≥ 4.5 μIU/mL group than in 1.0 ≤ TSH ≤ 1.9 μIU/mL group (96.32±14.19 versus 92.31±12.86 mmHg; P=0.040; 0.99±0.60 versus 0.87±0.34 mmol/L, P=0.023). Conclusion. OSA might be a risk factor for increased TSH even within reference range in hypertensive population.
format Article
id doaj-art-752d09f85263411f91a02bb500847264
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-752d09f85263411f91a02bb5008472642025-02-03T07:25:08ZengWileyInternational Journal of Endocrinology1687-83371687-83452016-01-01201610.1155/2016/48027204802720Thyroid Stimulating Hormone Is Increased in Hypertensive Patients with Obstructive Sleep ApneaNanfang Li0Mulalibieke Heizhati1Chao Sun2Suofeiya Abulikemu3Liang Shao4Xiaoguang Yao5Yingchun Wang6Jing Hong7Ling Zhou8Lei Wang9Yu Zhang10Weiwei Zhang11The Center for Hypertension of the People’s Hospital of Xinjiang Uygur Autonomous Region, The Center for Diagnosis, Treatment and Research of Hypertension in Xinjiang, No. 91, TianChi Road, Urumqi, Xinjiang 830001, ChinaThe Center for Hypertension of the People’s Hospital of Xinjiang Uygur Autonomous Region, The Center for Diagnosis, Treatment and Research of Hypertension in Xinjiang, No. 91, TianChi Road, Urumqi, Xinjiang 830001, ChinaThe Center for Hypertension of the People’s Hospital of Xinjiang Uygur Autonomous Region, The Center for Diagnosis, Treatment and Research of Hypertension in Xinjiang, No. 91, TianChi Road, Urumqi, Xinjiang 830001, ChinaThe Center for Hypertension of the People’s Hospital of Xinjiang Uygur Autonomous Region, The Center for Diagnosis, Treatment and Research of Hypertension in Xinjiang, No. 91, TianChi Road, Urumqi, Xinjiang 830001, ChinaThe Center for Hypertension of the People’s Hospital of Xinjiang Uygur Autonomous Region, The Center for Diagnosis, Treatment and Research of Hypertension in Xinjiang, No. 91, TianChi Road, Urumqi, Xinjiang 830001, ChinaThe Center for Hypertension of the People’s Hospital of Xinjiang Uygur Autonomous Region, The Center for Diagnosis, Treatment and Research of Hypertension in Xinjiang, No. 91, TianChi Road, Urumqi, Xinjiang 830001, ChinaThe Center for Hypertension of the People’s Hospital of Xinjiang Uygur Autonomous Region, The Center for Diagnosis, Treatment and Research of Hypertension in Xinjiang, No. 91, TianChi Road, Urumqi, Xinjiang 830001, ChinaThe Center for Hypertension of the People’s Hospital of Xinjiang Uygur Autonomous Region, The Center for Diagnosis, Treatment and Research of Hypertension in Xinjiang, No. 91, TianChi Road, Urumqi, Xinjiang 830001, ChinaThe Center for Hypertension of the People’s Hospital of Xinjiang Uygur Autonomous Region, The Center for Diagnosis, Treatment and Research of Hypertension in Xinjiang, No. 91, TianChi Road, Urumqi, Xinjiang 830001, ChinaThe Center for Hypertension of the People’s Hospital of Xinjiang Uygur Autonomous Region, The Center for Diagnosis, Treatment and Research of Hypertension in Xinjiang, No. 91, TianChi Road, Urumqi, Xinjiang 830001, ChinaThe Center for Hypertension of the People’s Hospital of Xinjiang Uygur Autonomous Region, The Center for Diagnosis, Treatment and Research of Hypertension in Xinjiang, No. 91, TianChi Road, Urumqi, Xinjiang 830001, ChinaThe Center for Hypertension of the People’s Hospital of Xinjiang Uygur Autonomous Region, The Center for Diagnosis, Treatment and Research of Hypertension in Xinjiang, No. 91, TianChi Road, Urumqi, Xinjiang 830001, ChinaPurpose. To evaluate alteration in serum TSH in hypertensives with OSA and its relation with cardiometabolic risk factors. Methods. 517 hypertensives were cross-sectionally studied. OSA was determined by polysomnography and thyroid function by standard methods. Results. OSA was diagnosed in 373 hypertensives (72.15%). Prevalence of subclinical hypothyroidism was significantly higher in OSA hypertensives than in non-OSA ones (15.0% versus 6.9%, P=0.014). Serum LnTSH in hypertensives with severe OSA was significantly higher (0.99±0.81 versus 0.74±0.77 μIU/mL, P<0.05) than in those without OSA. AHI, LSaO2, ODI3, and ODI4 were independently associated with serum TSH for those aged 30–65 years. Dividing subjects into four groups as TSH < 1.0 μIU/mL, 1.0 ≤ THS ≤ 1.9 μIU/mL, 1.91 ≤ TSH < 4.5 μIU/mL, and TSH ≥ 4.5 μIU/mL, only 26.3% of OSA subjects exhibited TSH between 1.0 and 1.9 μIU/mL, significantly less than non-OSA subjects (26.3% versus 38.2%, P=0.01). DBP and serum LDL-c elevated with TSH increasing and were only significantly higher in TSH ≥ 4.5 μIU/mL group than in 1.0 ≤ TSH ≤ 1.9 μIU/mL group (96.32±14.19 versus 92.31±12.86 mmHg; P=0.040; 0.99±0.60 versus 0.87±0.34 mmol/L, P=0.023). Conclusion. OSA might be a risk factor for increased TSH even within reference range in hypertensive population.http://dx.doi.org/10.1155/2016/4802720
spellingShingle Nanfang Li
Mulalibieke Heizhati
Chao Sun
Suofeiya Abulikemu
Liang Shao
Xiaoguang Yao
Yingchun Wang
Jing Hong
Ling Zhou
Lei Wang
Yu Zhang
Weiwei Zhang
Thyroid Stimulating Hormone Is Increased in Hypertensive Patients with Obstructive Sleep Apnea
International Journal of Endocrinology
title Thyroid Stimulating Hormone Is Increased in Hypertensive Patients with Obstructive Sleep Apnea
title_full Thyroid Stimulating Hormone Is Increased in Hypertensive Patients with Obstructive Sleep Apnea
title_fullStr Thyroid Stimulating Hormone Is Increased in Hypertensive Patients with Obstructive Sleep Apnea
title_full_unstemmed Thyroid Stimulating Hormone Is Increased in Hypertensive Patients with Obstructive Sleep Apnea
title_short Thyroid Stimulating Hormone Is Increased in Hypertensive Patients with Obstructive Sleep Apnea
title_sort thyroid stimulating hormone is increased in hypertensive patients with obstructive sleep apnea
url http://dx.doi.org/10.1155/2016/4802720
work_keys_str_mv AT nanfangli thyroidstimulatinghormoneisincreasedinhypertensivepatientswithobstructivesleepapnea
AT mulalibiekeheizhati thyroidstimulatinghormoneisincreasedinhypertensivepatientswithobstructivesleepapnea
AT chaosun thyroidstimulatinghormoneisincreasedinhypertensivepatientswithobstructivesleepapnea
AT suofeiyaabulikemu thyroidstimulatinghormoneisincreasedinhypertensivepatientswithobstructivesleepapnea
AT liangshao thyroidstimulatinghormoneisincreasedinhypertensivepatientswithobstructivesleepapnea
AT xiaoguangyao thyroidstimulatinghormoneisincreasedinhypertensivepatientswithobstructivesleepapnea
AT yingchunwang thyroidstimulatinghormoneisincreasedinhypertensivepatientswithobstructivesleepapnea
AT jinghong thyroidstimulatinghormoneisincreasedinhypertensivepatientswithobstructivesleepapnea
AT lingzhou thyroidstimulatinghormoneisincreasedinhypertensivepatientswithobstructivesleepapnea
AT leiwang thyroidstimulatinghormoneisincreasedinhypertensivepatientswithobstructivesleepapnea
AT yuzhang thyroidstimulatinghormoneisincreasedinhypertensivepatientswithobstructivesleepapnea
AT weiweizhang thyroidstimulatinghormoneisincreasedinhypertensivepatientswithobstructivesleepapnea